The latest research on the cellular and molecular biology of cancer from Oncogene

If you are unable to see the message below, click here to view.

Advertisement CRISPR: Predict Cas9 and sgRNA binding with accuracy Diagenode's iDeal ChIP-seq Kit for Transcription Factors: Latest method of choice to verify sgRNA specificity Uses robust ChIP method followed by qPCR to verify enrichment of dCas9 at expected target Sequencing analysis of the immunoprecipitated DNA shows off-target effects genome-wide Learn more and read the new application note.   TABLE OF CONTENTS Volume 37, Issue 37 In this issue Article Brief Communications Also new AOP   Advertisement ========================================== Register for the latest nature.com webcast ========================================== Distinct Metabolic Profiling of Invading PANC-1 Pancreatic Cancer Cells During this webcast Dr. Mayumi Fujita of the National Institutes for Quantum and Radiological Science and Technology in Japan will address the method of real-time imaging of invading cancer cells and describe how this model could be useful for other studies.  Register for FREE today  Sponsored by IncuCyte Article Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network Jie Ding, Chiuan-Ren Yeh, Yin Sun, Changyi Lin, Joshua Chou et al. Oncogene 2018 37 :5037 - 5053; May 23, 2018; 10.1038/s41388-018-0175-6   Abstract | Full Text Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells Andela Horvat, Jennifer M. Noto, Balamurugan Ramatchandirin, Elena Zaika, Manikandan Palrasu et al. Oncogene 2018 37 :5054 - 5065; May 30, 2018; 10.1038/s41388-018-0343-8   Abstract | Full Text PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence Mary E. Klein, Mark A. Dickson, Cristina Antonescu, Li-Xuan Qin, Scott J. Dooley et al. Oncogene 2018 37 :5066 - 5078; May 23, 2018; 10.1038/s41388-018-0332-y   Abstract | Full Text Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway Jian Chen, Wenjuan Li, Ke Cui, Kaiyuan Ji, Shuxiang Xu et al. Oncogene 2018 37 :5079 - 5087; May 24, 2018; 10.1038/s41388-018-0331-z   Abstract | Full Text Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment P. Xiao, Y. Guo, H. Zhang, X. Zhang, H. Cheng et al. Oncogene 2018 37 :5088 - 5100; May 24, 2018; 10.1038/s41388-018-0337-6   Abstract | Full Text RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling Chaido Sirinian, Anastasios D. Papanastasiou, Michail Schizas, Magda Spella, Georgios T. Stathopoulos et al. Oncogene 2018 37 :5101 - 5114; May 29, 2018; 10.1038/s41388-018-0324-y   Abstract | Full Text Melanoma protective antitumor immunity activated by catalytic DNA Hong Cai, Eun-Ae Cho, Yue Li, Jim Sockler, Christopher R. Parish et al. Oncogene 2018 37 :5115 - 5126; May 29, 2018; 10.1038/s41388-018-0306-0   Abstract | Full Text Brief Communications Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer Sara Al Habyan, Christina Kalos, Joseph Szymborski & Luke McCaffrey Oncogene 2018 37 :5127 - 5135; May 23, 2018; 10.1038/s41388-018-0317-x   Abstract | Full Text Shared and independent functions of aPKCλ and Par3 in skin tumorigenesis Susanne Vorhagen, Dominik Kleefisch, Oana-Diana Persa, Annika Graband, Alexandra Schwickert et al. Oncogene 2018 37 :5136 - 5146; May 23, 2018; 10.1038/s41388-018-0313-1   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.